Ohcanbohtosat - Heinz Reichmann

Aiddostahte ozu
  1. 1
    Clinical Criteria for the Diagnosis of Parkinson’s Disease

    Clinical Criteria for the Diagnosis of Parkinson’s Disease Dahkki Heinz Reichmann

    Almmustuhtton 2010
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Premotor Diagnosis of Parkinson’s Disease

    Premotor Diagnosis of Parkinson’s Disease Dahkki Heinz Reichmann

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Treatment of Parkinson’s disease in the advanced stage

    Treatment of Parkinson’s disease in the advanced stage Dahkki Christiana Ossig, Heinz Reichmann

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology

    Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology Dahkki Francisco Pan‐Montojo, Heinz Reichmann

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Pathophysiology of the MELAS 3243 Transition Mutation

    Pathophysiology of the MELAS 3243 Transition Mutation Dahkki Adrian Flierl, Heinz Reichmann, Peter Seibel

    Almmustuhtton 1997
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Olfactory Loss in Parkinson's Disease

    Olfactory Loss in Parkinson's Disease Dahkki Antje Haehner, Thomas Hummel, Heinz Reichmann

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Different Odor Tests Contribute Differently to the Evaluation of Olfactory Loss

    Different Odor Tests Contribute Differently to the Evaluation of Olfactory Loss Dahkki Jörn Lötsch, Heinz Reichmann, Thomas Hummel

    Almmustuhtton 2007
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Restless legs syndrome

    Restless legs syndrome Dahkki Lisa Klingelhoefer, Kalyan Bhattacharya, Heinz Reichmann

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    The use of wearables for the diagnosis and treatment of Parkinson’s disease

    The use of wearables for the diagnosis and treatment of Parkinson’s disease Dahkki Heinz Reichmann, Lisa Klingelhoefer, Jonas Bendig

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Parkinson’s disease between internal medicine and neurology

    Parkinson’s disease between internal medicine and neurology Dahkki Ilona Csóti, Wolfgang H. Jost, Heinz Reichmann

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases

    Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases Dahkki Peter Seibel, Jörg Trappe, Gaetano Villani, Thomas Klopstock, Sergio Papa, Heinz Reichmann

    Almmustuhtton 1995
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Olfactory loss may be a first sign of idiopathic Parkinson's disease

    Olfactory loss may be a first sign of idiopathic Parkinson's disease Dahkki Antje Haehner, Thomas Hummel, Cornelia Hummel, Ülrike Sommer, Susann Junghanns, Heinz Reichmann

    Almmustuhtton 2007
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Microcurrent Transcutaneous Electric Nerve Stimulation in Painful Diabetic Neuropathy: A Randomized Placebo-Controlled Study

    Microcurrent Transcutaneous Electric Nerve Stimulation in Painful Diabetic Neuropathy: A Randomized Placebo-Controlled Study Dahkki Gudrun Goßrau, Michael Wähner, Marion Kuschke, Birgit Konrad, Heinz Reichmann, B. Wiedemann, R. Sabatowski

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

    Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study Dahkki Heinz Reichmann, Andrew J. Lees, José‐Francisco Rocha, Diogo Magalhães, Patrício Soares‐da‐Silva

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Life style and Parkinson’s disease

    Life style and Parkinson’s disease Dahkki Heinz Reichmann, Ilona Csóti, Jiri Koschel, Stefan Lorenzl, Christoph Schrader, Jürgen Winkler, Ullrich Wüllner

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Pneumonia and in-hospital mortality in the context of neurogenic oropharyngeal dysphagia (NOD) in stroke and a new NOD step-wise concept

    Pneumonia and in-hospital mortality in the context of neurogenic oropharyngeal dysphagia (NOD) in stroke and a new NOD step-wise concept Dahkki Guntram W. Ickenstein, Axel Riecker, C. Höhlig, Rainer Müller, Ulrik Becker, Heinz Reichmann, Mario Prosiegel

    Almmustuhtton 2010
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS

    Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS Dahkki Katja Akgün, Nicole Kretschmann, Rocco Haase, Undine Proschmann, Hagen H. Kitzler, Heinz Reichmann, Tjalf Ziemssen

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function

    CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function Dahkki Duohui Jing, Uta Oelschlaegel, Rainer Ordemann, Kristina Hölig, Gerhard Ehninger, Heinz Reichmann, Tjalf Ziemssen, Martin Bornhäuser

    Almmustuhtton 2010
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Olfactory Training in Patients with Parkinson's Disease

    Olfactory Training in Patients with Parkinson's Disease Dahkki Antje Haehner, Clara Tosch, Martin Wolz, Lisa Klingelhoefer, Mareike Fauser, Alexander Storch, Heinz Reichmann, Thomas Hummel

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Static posturography in aging and Parkinson's disease

    Static posturography in aging and Parkinson's disease Dahkki Guntram W. Ickenstein, Helmut Ambach, Antonia Klöditz, Horst J. Koch, Stefan Isenmann, Heinz Reichmann, Tjalf Ziemssen

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: